Christophe I.
- Country
- France
- Department
- Pôle MOPHA
Research Overview
Data & Insights
Has run more than one trial at 0 of 2 partner sites.
Specializations
Addiction Medicine
The investigator specializes in the treatment of benzodiazepine dependence and substance use disorders, with particular focus on innovative therapeutic approaches for medication-assisted treatment.
- Benzodiazepine Use Disorder
- Medication-Assisted Treatment
- Substance Dependence Management
Clinical interests include developing protocols for safe benzodiazepine dose reduction and exploring alternative therapeutic agents.
Psychiatric Care
Active in the field of psychiatric disorders, the investigator focuses on the intersection of mental health conditions and substance use disorders.
- Anxiety Disorders
- Dual Diagnosis Treatment
- Psychopharmacology
The therapeutic approach encompasses comprehensive psychiatric evaluation and treatment of co-occurring mental health conditions.
Therapeutic Innovation
The investigator explores novel applications of pharmacological interventions in addiction treatment, particularly focusing on alternative medications for dependency management.
- Novel Therapeutic Approaches
- Drug Safety Evaluation
- Treatment Optimization
Areas of interest include the development of evidence-based protocols for medication-assisted treatment in addiction medicine.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.